title: Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial.
abstract: BACKGROUND
  The clinical presentation of primary hyperparathyroidism (pHPT) has changed during the last half century, and the diagnosis is now more often made by chance in patients with no specific symptoms.
  
  
  OBJECTIVE
  The present study is a randomized, controlled trial that investigates the effects of parathyroidectomy or medical observation in mild asymptomatic pHPT on morbidity and quality of life (QoL).
  
  
  METHODS
  A total of 191 patients (26 men) with asymptomatic pHPT [mean age 64.2 +/- 7.4 (sd) yr] were recruited in the study and randomized to medical observation (serum calcium level 2.69 +/- 0.08 mmol/liter) or surgery (2.70 +/- 0.08 mmol/liter). We here report baseline and 1 (n = 119) and 2 yr data (n = 99) on those who had completed the follow-up visits by the end of the inclusion period.
  
  
  RESULTS
  At baseline, the patients had significantly lower QoL (SF-36) and more psychological symptoms, compared with age- and sex-matched healthy subjects. The two groups were similar at baseline, and no clinically significant changes in these parameters were seen during the observation time. Calcium and PTH normalized after surgery. The areal bone mineral density increased in the group randomized to operation, whereas the bone mineral density remained stable in the medical observation group. No change in kidney function (creatinine) or blood pressure was observed longitudinally or between the groups.
  
  
  CONCLUSIONS
  Asymptomatic patients with mild pHPT have decreased QoL and more psychological symptoms than normal controls. No benefit of operative treatment, compared with medical observation, was found on these measures so far.
authors.affiliation: Section of Endocrinology, Department of Medicine, Rikshospitalet-Radiumhospitalet Medical Center, National University Hospital, N-0027 Oslo, Norway. jens.bollerslev@medisin.uio.no
authors.forename: Jens
authors.initials: J
authors.lastname: Bollerslev
authors.forename: Svante
authors.initials: S
authors.lastname: Jansson
authors.forename: Charlotte L
authors.initials: CL
authors.lastname: Mollerup
authors.forename: Jörgen
authors.initials: J
authors.lastname: Nordenström
authors.forename: Eva
authors.initials: E
authors.lastname: Lundgren
authors.forename: Ove
authors.initials: O
authors.lastname: Tørring
authors.forename: Jan-Erik
authors.initials: JE
authors.lastname: Varhaug
authors.forename: Marek
authors.initials: M
authors.lastname: Baranowski
authors.forename: Sylvi
authors.initials: S
authors.lastname: Aanderud
authors.forename: Celina
authors.initials: C
authors.lastname: Franco
authors.forename: Bo
authors.initials: B
authors.lastname: Freyschuss
authors.forename: Gunhild A
authors.initials: GA
authors.lastname: Isaksen
authors.forename: Thor
authors.initials: T
authors.lastname: Ueland
authors.forename: Thord
authors.initials: T
authors.lastname: Rosen
mesh_terms: D000368:Aged; D001794:Blood Pressure / Q000502:physiology; D015519:Bone Density; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000523:psychology / Q000601:surgery* / Q000628:therapy*; D007677:Kidney Function Tests; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D016105:Parathyroidectomy; D011379:Prognosis; D011446:Prospective Studies; D011788:Quality of Life; D011795:Surveys and Questionnaires